Sunday, 25 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
CSPC Pharmaceutical Group Gains NMPA Approval for SYS6040 Clinical Trial
March 24, 2025
Company
Duality Biotherapeutics Clears HKEX Hearing, Set for IPO with $2.7B Valuation
March 24, 2025
Company
China Biopharmaceutical Leads AI Integration with DeepSeek-R1
March 23, 2025
Policy / Regulatory
Driving Innovation in Traditional Chinese Medicine: A Policy-Backed Renaissance
March 22, 2025
Company
Medical Device
GE Healthcare Unveils Invenia ABUS Premium for Enhanced Dense Breast Screening
March 21, 2025
Company
Drug
Daiichi Sankyo Launches Datroway in Japan for HR Positive, HER2 Negative Breast Cancer
March 21, 2025
Company
Deals
Porton Pharma Solutions’ Porton Advanced Partners with Eureka Therapeutics on T-Cell Therapies
March 21, 2025
Company
Drug
Triastek’s 3D-Printed T20G Receives US Clinical Approval for NOAC Treatment
March 21, 2025
Company
Drug
Johnson & Johnson’s Tremfya Gains FDA Approval for Crohn’s Disease Treatment
March 21, 2025
Company
Deals
Menarini Group Partners with VisualDx to Enhance BPDCN Identification Using AI/ML Tools
March 21, 2025
Company
Drug
Elevation Oncology Halts EO-3021 Development After Poor Phase 1 Data
March 21, 2025
Company
Drug
Changchun High & New Technology Industries Receives US Trial Approval for GenSci120 in Rheumatoid Arthritis
March 21, 2025
1
2
…
10
11
12
13
14
…
31
32
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
